Your browser doesn't support javascript.
loading
EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma.
Rosenberg, J E; Powles, T; Sonpavde, G P; Loriot, Y; Duran, I; Lee, J-L; Matsubara, N; Vulsteke, C; Castellano, D; Mamtani, R; Wu, C; Matsangou, M; Campbell, M; Petrylak, D P.
Afiliación
  • Rosenberg JE; Department of Medicine, Division of Solid Tumor Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Powles T; Department of Genitourinary Oncology, Barts Cancer Institute, CRUK Experimental Cancer Medicine Centre, London, UK.
  • Sonpavde GP; Department of Bladder Cancer, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Loriot Y; Department of Renal Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Duran I; Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Lee JL; Department of Oncology, Urologic Cancer center, Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea.
  • Matsubara N; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Vulsteke C; Department of Molecular Imaging - Pathology - Radiotherapy - Oncology, Center for Oncological Research (CORE), University of Antwerp, Integrated Cancer Center Ghent, Ghent, Belgium.
  • Castellano D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Mamtani R; Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia.
  • Wu C; Department of Biostatistics.
  • Matsangou M; Department of Therapeutic Area-Oncology, Astellas Pharma, Inc., Northbrook.
  • Campbell M; Department of Late Stage Development, Seagen Inc., Bothell.
  • Petrylak DP; Department of Medicine and Urology, Yale Cancer Center, New Haven, USA. Electronic address: daniel.petrylak@yale.edu.
Ann Oncol ; 34(11): 1047-1054, 2023 11.
Article en En | MEDLINE | ID: mdl-37678672
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido